Pure Global
NCT03515863

Natural History and Risk Factors of TAO

Natural History and Genetic Risk Factors of Thyroid Associated Ophthalmopathy (TAO)
Sun Yat-sen University·ClinicalTrials.gov·genetic
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Thyroid Associated Ophthalmopathy
Drug/Device/Intervention
DNA extraction and genetic characterization
Study type
Observational
Intervention type
genetic
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou,Zhaoqing, China
Timeline & enrollment
Phase
N/A
Start date
May 15, 2018
End date
May 09, 2022
Enrollment
400 participants
Primary outcome

Genetic risk factors of TAO predisposition

Summary

The aim of this study is to complete the identification of genetic factors predisposing to
 thyroid associated ophthalmopathy (TAO) by constituting a cohort of 400 Grave's patients with
 or without ocular signs.

ICD-10 classifications
ThyroiditisDisorders of thyroid glandThyroiditis, unspecifiedOther disorders of thyroidDisorder of thyroid, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03515863
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03515863 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently status unknown. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.